Drinking water composition and incidence of urinary calculus

Iranian Journal of Kidney Diseases

Volumn 5, Issue 1, 2011, Pages 15-20

  Basiri, Abbas ^a   Shakhssalim, Nasser ^a   Khoshdel, Ali Reza ^b   Pakmanesh, Hamid ^a   Radfar, Mohammad Hadi ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium; Magnesium; Urinary calculi; Water supply

Indexed keywords

BICARBONATE; CALCIUM; MAGNESIUM;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROLYTE URINE LEVEL; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; RISK ASSESSMENT; UROLITHIASIS; WATER CONTENT; WATER HARDNESS; WATER QUALITY;

BICARBONATES; CALCIUM; ELECTROLYTES; HUMANS; INCIDENCE; IRAN; MAGNESIUM; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS; URINARY CALCULI; WATER SUPPLY;

EID: 79251514658     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Wickham JEA, Buck AC. Renal tract stone: metabolic basis and clinical practice. Edinburgh: Churchill Livingstone; 1990.
2. Sierakowski R, Finlayson B, Landes R. Stone incidence as related to water hardness in different geographical regions of the United States. Urol Res. 1979;7:157-60.
3. Churchill D, Bryant D, Fodor G, Gault MH. Drinking water hardness and urolithiasis. Ann Intern Med. 1978;88:513-4.
4. Shuster J, Finlayson B, Scheaffer R, Sierakowski R, Zoltek J, Dzegede S. Water hardness and urinary stone disease. J Urol. 1982;128:422-5.
5. Schwartz BF, Bruce J, Leslie S, Stoller ML. Rethinking the role of urinary magnesium in calcium urolithiasis. J Endourol. 2001;15:233-5.
6. Bellizzi V, De Nicola L, Minutolo R, et al. Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis. Nephron. 1999;81 Suppl 1:66-70.
7. Singh PP, Kiran R. Are we overstressing water quality in urinary stone disease? Int Urol Nephrol. 1993;25:29-36.
8. Caudarella R, Rizzoli E, Buffa A, Bottura A, Stefoni S. Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol. 1998;159:658-63.
9. Barker DJ, Donnan SP. Regional variations in the incidence of upper urinary tract stones in England and Wales. Br Med J. 1978;1:67-70.
10. Alapont Perez FM, Galvez Calderon J, Varea Herrero J, Colome Borros G, Olaso Oltra A, Sanchez Bisono JR. [Epidemiology of urinary lithiasis]. Actas Urol Esp. 2001;25:341-349. Spanish.
11. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13 Suppl 3:S45-50.
12. Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson B. Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures. Am J Epidemiol. 1998;147:914-20.
13. Li MK, Blacklock NJ, Garside J. Effects of magnesium on calcium oxalate crystallization. J Urol. 1985;133:123-5.
14. Zerwekh JE, Odvina CV, Wuermser LA, Pak CY. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol. 2007;177: 2179-84.
15. Reungjui S, Prasongwatana V, Premgamone A, Tosukhowong P, Jirakulsomchok S, Sriboonlue P. Magnesium status of patients with renal stones and its effect on urinary citrate excretion. BJU Int. 2002;90:635-9.
16. Kohri K, Garside J, Blacklock NJ. The role of magnesium in calcium oxalate urolithiasis. Br J Urol. 1988;61:107-15.
17. Khan SR, Shevock PN, Hackett RL. Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis. J Urol. 1993;149:412-6.
18. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158:2069-73.
19. Gershoff SN, Prien EL. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones. Am J Clin Nutr. 1967;20:393-9.
20. Johansson G, Backman U, Danielson BG, Fellstrom B, Ljunghall S, Wikstrom B. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol. 1980;124:770-4.
21. Kohri K, Kodama M, Ishikawa Y, et al. Magnesium-tocalcium ratio in tap water, and its relationship to geological features and the incidence of calcium-containing urinary stones. J Urol. 1989;142:1272-5.
22. Kohri K, Ishikawa Y, Iguchi M, Kurita T, Okada Y, Yoshida O. Relationship between the incidence infection stones and the magnesium-calcium ratio of tap water. Urol Res. 1993;21:269-72.
23. Basiri A, Shakhssalim N, Khoshdel AR, Naghavi M. Regional and seasonal variation in the incidence of urolithiasis in Iran: a place for obsession in case finding and statistical approach. Urol Res. 2009.
24. Water Quality Association [homepage on the internet]. Centralized "water softening" - know the facts [cited 26 Jul, 2008]. Available from: http://www.wqa.org/sitelogic.cfm?ID=1052.
25. Desmars JF, Tawashi R. Dissolution and growth of calcium oxalate monohydrate. I. Effect of magnesium and pH. Biochim Biophys Acta. 1973;313:256-67.
26. Meyer JL, Smith LH. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol. 1975;13:36-9.
27. Coen G, Sardella D, Barbera G, et al. Urinary composition and lithogenic risk in normal subjects following oligomineral versus bicarbonate-alkaline high calcium mineral water intake. Urol Int. 2001;67:49-53.